Vaccine Adjuvant
Salmonella flagellin component potentiates immune responses
Published in Vaccine Weekly, November 16th, 2005
According to recent research from the United States, "An expanding area of interest is the utilization of microbe-based components to augment mucosal and systemic immune responses to target antigens. Thus, the aim of the present study was to assess if the flagellin component FljB from Salmonella enterica serovar Typhimurium could act as a mucosal adjuvant and then to determine the cellular mechanisms by which FljB mediates its adjuvant properties. To determine if FljB could act as a mucosal adjuvant, mice were immunized by the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-11-16)
More Articles from Vaccine Weekly
- Anthrax Vaccine Development
Monoclonal antibody protects against anthrax toxin - Atherosclerosis Vaccine Development
Chimeric enzyme vaccine attenuated atherosclerosis in rabbit model - Hookworm Vaccine Development
Hookworm heme-binding glutathione transferase has vaccine potential - Meningitis Vaccine Development
Anti-idiotypic antibody is candidate for meningitis vaccine - Allergy Medicine
Recent findings in allergy medicine provide new insights - Apoptosis
Alpha-tocopheryl succinate selectively induced apoptosis in neuroblastoma cells - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
